Please assess the completion status of the following clinical trial:

Trial Title: Cannabis and Thought Disorder in Schizophrenia

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Aged between 18 and 65~* Meeting the DSM-5 criteria for schizophrenia~* Cannabis user group: - Smoking at least two days per week during the previous months~* Displaying positive urine screen for cannabis~* Non-cannabis user group: - No episode of cannabis smoking during the previous month~* Negative urine screen for cannabis + no lifetime criteria for cannabis use disorder (assessment by an addiction specialist).~Exclusion Criteria:~* Current criteria for axis-1 psychiatric disorder other than schizophrenia~* Current criteria for any other substance use disorder except for nicotine use disorder~* Any contraindication for MRI~* Tutorship or curatorship~* Pregnant or lactating woman

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Cannabis users (Type: EXPERIMENTAL): Subjects of this group have to meet the DSM-5 criteria for schizophrenia and smoke cannabis at least two days per week for every week of the past month. They have to exhibit negative urine screen for any substance except benzodiazepines and cannabis.
- Non- cannabis users (control group) (Type: ACTIVE_COMPARATOR): Subjects of this group have to meet the DSM-5 criteria for schizophrenia and have to report no cannabis use over the previous month, and exhibit negative urine screen for any substance except benzodiazepines.

Based on this trial design, predict the completion outcome and termination type (if applicable).